MyAverix Finance
US · Healthcare
Bio-Rad Laboratories Inc (BIO-B)
Medical Devices
Bio-Rad Laboratories Inc (BIO-B) is listed on US in the Healthcare sector. Industry: Medical Devices. As of 2026-03-30, reported market cap is $7.25B, P/E ratio is 9.64, net margin is 29.4%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for BIO-B
Bio-Rad Laboratories Inc (BIO-B) — FAQ
What is Bio-Rad Laboratories Inc's market cap?
Bio-Rad Laboratories Inc (BIO-B) has a reported market cap of $7.25B (data as of 2026-03-30).
What is BIO-B's P/E ratio?
The price-to-earnings (P/E) ratio for Bio-Rad Laboratories Inc (BIO-B) is 9.64 (data as of 2026-03-30).
Does Bio-Rad Laboratories Inc pay a dividend?
Dividend yield is not available in the current snapshot for Bio-Rad Laboratories Inc (BIO-B). Check the MyAverix Finance app for the latest dividend data.
What sector is Bio-Rad Laboratories Inc in?
Bio-Rad Laboratories Inc (BIO-B) is classified in the Healthcare sector (Medical Devices industry).
What exchange is BIO-B listed on?
BIO-B is listed on US.
What is Bio-Rad Laboratories Inc's net margin?
Bio-Rad Laboratories Inc (BIO-B) reports a net margin of 29.4% (data as of 2026-03-30).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.